ChARM
ChARM aims to be the leading company in diagnosing pneumonia in children under 5 in low-resource settings. 900.000 children under 5 are dying per year from pneumonia because of poor diagnosis of pneumonia & inappropriate treatment. ChARM will be the tool to support the correct diagnosis.
The children’s automated respiration rate monitor (ChARM)
A call for technology to industry resulted in the development of an automated Respiration Rate (RR) monitor named the Children’s Automated Respiration Monitor (a.k.a. ChARM) which is a CE mark Class IIa medical device, that automatically detects the breathing rate of a child, helping care providers diagnose fast breathing, a key vital sign in diagnosing pneumonia.
ChARM is the venture that will bring a battery-powered breathing rate monitor
ChARM is the venture that will bring a battery-powered breathing rate monitor ( CE class IIa medical device ), designed to help with the diagnosis of pneumonia and reduce childhood deaths caused by pneumonia.
ChARM aims to be the leading company in diagnosing pneumonia in children under 5 in low-resource settings
ChARM will solve the unmet need by enabling frontline health workers to correctly diagnose pneumonia with children < 5y to make simple treatment with low-cost medicine possible. The ambition is to save 100's of 1000 children from dying, positively impact million children's health, and to fight Anti Microbial Resistance
Our team
Partners
